Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisNEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Alemtuzumab for Multiples Sclerosis: Who and When to treat?Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012